The Role of STAT1/IRF-1 on Synergistic ROS Production and Loss of Mitochondrial Transmembrane Potential during Hepatic Cell Death Induced by LPS/d-GalN

Journal of Molecular Biology

Volumn 369, Issue 4, 2007, Pages 967-984

  Lee, Hyun Jung ^a   Oh, Yeo Kyoung ^a   Rhee, Marie ^a   Lim, Joong Yeon ^a   Hwang, Ji Young ^a   Park, Yoon Shin ^a   Kwon, Yongil ^b   Choi, Kyung Hee ^c   Jo, Inho ^a   Park, Sang Ick ^a   Gao, Bin ^d   Kim, Won Ho ^a  

^a Korea National Institute of Health   (South Korea)

^b Hallym University   (South Korea)

^c Department of Biology   (South Korea)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

hepatitis; iNOS; liver injury; ROS; STAT1

Indexed keywords

ACETYLCYSTEINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GALACTOSAMINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; CELL DEATH; CELL MEMBRANE POTENTIAL; CELL THERAPY; COMPARATIVE STUDY; CYTOKINE RELEASE; ENZYME SYNTHESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIVER CELL; LIVER INJURY; MALE; MOUSE; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; WILD TYPE;

MUS;

EID: 34248579219     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.03.072     Document Type: Article

References (40)

1. Kimura T., Itoh N., Takehara M., Oguro I., Ishizaki J.I., Nakanishi T., and Tanaka K. Sensitivity of metallothionein-null mice to LPS/d-galactosamine-induced lethality. Biochem. Biophys. Res. Commun. 280 (2001) 358-362
2. Wang H., and Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. Eur. J. Pharmacol. 534 (2006) 194-201
3. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103 (2000) 1071-1083
4. Akashi-Takamura S., Furuta T., Takahashi K., Tanimura N., Kusumoto Y., Kobayashi T., et al. Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-alpha. J. Immunol. 176 (2006) 4244-4251
5. Higuchi Y., Kawakami S., Oka M., Yamashita F., and Hashida M. Suppression of TNFalpha production in LPS induced liver failure in mice after intravenous injection of cationic liposomes/NFkappaB decoy complex. Pharmazie 61 (2006) 144-147
6. Ding W.X., and Yin X.M. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J. Cell Mol. Med. 8 (2004) 445-454
7. Haas C., Car B., Ryffel B., and Le Hir M. Lipopolysaccharide-induced glomerulonephritis develops in the absence of interferon-gamma signaling. Exp. Nephrol. 4 (1996) 222-230
8. Heremans H., Dillen C., Groenen M., Matthys P., and Billiau A. Role of interferon-gamma and nitric oxide in pulmonary edema and death induced by lipopolysaccharide. Am. J. Respir. Crit. Care. Med. 161 (2000) 110-117
9. Hong F., Jaruga B., Kim W.H., Radaeva S., El Assal O.N., Tian Z., et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110 (2002) 1503-1513
10. Kim W.H., Hong F., Radaeva S., Jaruga B., Fan S., and Gao B. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury. Am. J. Physiol. Gastrointest Liver Physiol. 285 (2003) G761-G768
11. Jaruga B., Hong F., Kim W.H., and Gao B. IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am. J. Physiol. Gastrointest. Liver. Physiol. 287 (2004) G1044-G1052
12. Schweyer S., Mihm S., Radzun H.J., Hartmann H., and Fayyazi A. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut 46 (2000) 255-259
13. Sass G., Koerber K., Bang R., Guehring H., and Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 107 (2001) 439-447
14. Guler R., Olleros M.L., Vesin D., Parapanov R., Vesin C., Kantengwa S., et al. Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J. Hepatol. 41 (2004) 773-781
15. Liu M.Y., Cheng Y.J., Chen C.K., and Yang B.C. Coexposure of lead- and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-alpha. Shock 23 (2005) 360-364
16. Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., and Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol. Sci. 65 (2002) 166-176
17. Kondo S., Toyokuni S., Tsuruyama T., Ozeki M., Tachibana T., Echizenya M., et al. Peroxynitrite-mediated stress is associated with proliferation of human metastatic colorectal carcinoma in the liver. Cancer Lett. 179 (2002) 87-93
18. Vodovotz Y., Kim P.K., Bagci E.Z., Ermentrout G.B., Chow C.C., Bahar I., and Billiar T.R. Inflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo, in vitro, and in silico studies. Curr. Mol. Med. 4 (2004) 753-762
19. Rane S.G., and Reddy E.P. Janus kinases: components of multiple signaling pathways. Oncogene 19 (2000) 5662-5679
20. Guzik T.J., Korbut R., and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54 (2003) 469-487
21. Hampel B., Malisan F., Niederegger H., Testi R., and Jansen-Durr P. Differential regulation of apoptotic cell death in senescent human cells. Exp. Gerontol. 39 (2004) 1713-1721
22. Yoon S.O., Yun C.H., and Chung A.S. Dose effect of oxidative stress on signal transduction in aging. Mech. Ageing Dev. 123 (2002) 1597-1604
23. Le Bras M., Clement M.V., Pervaiz S., and Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Histopathol. 20 (2005) 205-219
24. Morikawa A., Koide N., Sugiyama T., Mu M.M., Hassan F., Islam S., et al. The enhancing action of d-galactosamine on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. FEMS Immunol. Med. Microbiol. 41 (2004) 211-218
25. Kim B.C., Choi J.W., Hong H.Y., Lee S.A., Hong S., Park E.H., et al. Heme oxygenase-1 mediates the anti-inflammatory effect of mushroom Phellinus linteus in LPS-stimulated RAW264.7 macrophages. J. Ethnopharmacol. 106 (2006) 364-371
26. Campbell K.J., and Perkins N.D. Regulation of NF-kappaB function. Biochem. Soc. Symp. 73 (2006) 165-180
27. Collett G.P., and Campbell F.C. Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27 (2006) 1285-1291
28. Kim H.S., and Lee M.S. Essential role of STAT1 in caspase-independent cell death of activated macrophages through the p38 mitogen-activated protein kinase/STAT1/reactive oxygen species pathway. Mol. Cell. Biol. 25 (2005) 6821-6833
29. Ganster R.W., Taylor B.S., Shao L., and Geller D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc. Natl Acad. Sci. USA 98 (2001) 8638-8643
30. El Assal O., Hong F., Kim W.H., Radaeva S., and Gao B. IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver. Cell Mol. Immunol. 1 (2004) 205-211
31. Schottelius A.J., and Dinter H. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat. Res. 130 (2006) 67-87
32. Anan A., Baskin-Bey E.S., Bronk S.F., Werneburg N.W., Shah V.H., and Gores G.J. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 43 (2006) 335-344
33. Ischiropoulos H., Zhu L., and Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298 (1992) 446-451
34. Llovera M., Pearson J.D., Moreno C., and Riveros-Moreno V. Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Br. J. Pharmacol. 132 (2001) 419-426
35. Bernal-Mizrachi L., Lovly C.M., and Ratner L. The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc. Natl. Acad. Sci. USA 103 (2006) 9220-9225
36. Lamkanfi M., Declercq W., Vanden Berghe T., and Vandenabeele P. Caspases leave the beaten track: caspase-mediated activation of NF-kappaB. J. Cell Biol. 173 (2006) 165-171
37. Shen X., Tian Z., Holtzman M.J., and Gao B. Cross-talk between interleukin 1β (IL-1β) and IL-6 signaling pathways: IL-1β selectively inhibits IL-6-activated signal transduced and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism. Biochem. J. 352 (2000) 913-919
38. Nakajima K., Yamanaka Y., Nakae K., Kojima H., Ichiba M., Kiuchi N., et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15 (1996) 3651-3658
39. Kim W.H., Lee J.W., Gao B., and Jung M.H. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal. 17 (2005) 1516-1532
40. Tunon M.J., Sanchez-Campos S., Gutierrez B., Culebras J.M., and Gonzalez-Gallego J. Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes. Biochem. Pharmacol. 66 (2003) 439-445